Drug Information

Drug General Information
Drug ID
D0W9JM
Former ID
DNC007479
Drug Name
KNI-272
Drug Type
Small molecular drug
Indication Human immunodeficiency virus infection [ICD9: 279.3; ICD10:B20-B26] Phase 2 [544490]
Structure
Download
2D MOL

3D MOL
Formula
C33H41N5O6S2
Canonical SMILES
CC(C)(C)NC(=O)C1CSCN1C(=O)C(C(CC2=CC=CC=C2)NC(=O)C(CSC)<br />NC(=O)COC3=CC=CC4=C3C=CN=C4)O
InChI
1S/C33H41N5O6S2/c1-33(2,3)37-31(42)26-19-46-20-38(26)32(43)29(40)24(15-21-9-6-5-7-10-21)36-30(41)25(18-45-4)35-28(39)17-44-27-12-8-11-22-16-34-14-13-23(22)27/h5-14,16,24-26,29,40H,15,17-20H2,1-4H3,(H,35,39)(H,36,41)(H,37,42)/t24?,25-,26-,29?/m0/s1
InChIKey
NJBBLOIWMSYVCQ-OKHMJZBSSA-N
PubChem Compound ID
374224
Target and Pathway
Target(s) HIV protease Target Info Modulator
References
Ref 544490Metabolic Characterization of a Tripeptide Human Immunodeficiency Virus Type 1 Protease Inhibitor, KNI-272, in Rat Liver Microsomes. Antimicrob Agents Chemother. 1999 March; 43(3): 549-556.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.